Sjögren's syndrome: a critical review of clinical management.
Mary Bell(Health Sciences Centre), Allan R. Slomovic(University of Toronto), Charles C. Muscoplat(Utah State University), Seymour Frydrych(University of Toronto), John Lamont(University of Toronto), Arthur Bookman(University of Toronto), Ali Askari(University of Toronto), John McComb(University of Toronto)
PubMed
September 1, 1999
Cited by 61
Related Papers
Oral Pilocarpine for Post-Irradiation Xerostomia in Patients with Head and Neck Cancer
|New England Journal of Medicine|1993|483
A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients.
|Journal of Clinical Oncology|1993|292
The experience and impact of chronic disease peer support interventions: A qualitative synthesis
|Patient Education and Counseling|2013|259
Oral pilocarpine for radiation-induced xerostomia: Integrated efficacy and safety results from two prospective randomized clinical trials
|International Journal of Radiation Oncology*Biology*Physics|1995|139